Correlation Between Stryker and Cytek Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Stryker and Cytek Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stryker and Cytek Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stryker and Cytek Biosciences, you can compare the effects of market volatilities on Stryker and Cytek Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stryker with a short position of Cytek Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stryker and Cytek Biosciences.

Diversification Opportunities for Stryker and Cytek Biosciences

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Stryker and Cytek is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Stryker and Cytek Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytek Biosciences and Stryker is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stryker are associated (or correlated) with Cytek Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytek Biosciences has no effect on the direction of Stryker i.e., Stryker and Cytek Biosciences go up and down completely randomly.

Pair Corralation between Stryker and Cytek Biosciences

Considering the 90-day investment horizon Stryker is expected to generate 0.32 times more return on investment than Cytek Biosciences. However, Stryker is 3.16 times less risky than Cytek Biosciences. It trades about 0.08 of its potential returns per unit of risk. Cytek Biosciences is currently generating about -0.01 per unit of risk. If you would invest  25,189  in Stryker on September 3, 2024 and sell it today you would earn a total of  14,026  from holding Stryker or generate 55.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Stryker  vs.  Cytek Biosciences

 Performance 
       Timeline  
Stryker 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Stryker are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating basic indicators, Stryker may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Cytek Biosciences 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cytek Biosciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak forward-looking signals, Cytek Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Stryker and Cytek Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Stryker and Cytek Biosciences

The main advantage of trading using opposite Stryker and Cytek Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stryker position performs unexpectedly, Cytek Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytek Biosciences will offset losses from the drop in Cytek Biosciences' long position.
The idea behind Stryker and Cytek Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Transaction History
View history of all your transactions and understand their impact on performance